Psoriatic Arthritis Market, By Drug Class (DMARD, NSAIDs, Biologics, and Others), By Product Type (OTC and Prescriptions), By Route of Administration (Oral, Topical, and Injectable), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Psoriatic arthritis is a type of arthritis that affects some people with psoriasis - a disease that causes red patches with silvery scales on the skin. Symptoms include joint pain, stiffness, and swelling, which may flare up and subside. Many people with this condition suffer from morning stiffness, Psoriatic arthritis is affect joints on one or both sides of your body. The signs and symptoms of psoriatic arthritis are often similar to rheumatoid arthritis. Both diseases cause joint pain, swelling and warmth to the touch. The increasing prevalence of psoriatic arthritis, an autoimmune disorder caused by the body's immune system attacking the joints and skin, is poised to increase the demand for psoriatic arthritis drugs for treatment. A stressful lifestyle leads to overstimulation of the immune system; Rapid growth of geriatric population, increasing prevalence of psoriasis, rising incomes leading to increased affordability for high-cost biological products, and increasing number of new product approvals are some of the major factors driving the growth of the psoriatic arthritis treatment market. The global psoriatic arthritis market accounted for US$ 6.9 billion in 2020 and is estimated to be US$ 14.8 billion by 2029 and is anticipated to register a CAGR of 9.0%.

Rise in Prevalence of Psoriatic Arthritis and Advancement in the therapeutics

Psoriatic arthritis patients are increasing every year. According to a publication in the International Journal of Clinical Rheumatology, psoriatic arthritis is considered a part of the spondyloarthritis group, which is present in 42% of individuals with psoriasis and 15% of patients with psoriasis may have undiagnosed psoriatic arthritis. Increase in drugs along with increasing cases and thereby diagnosis is driving the psoriatic arthritis market. Advances in the development of personalized medicine have been made over the past few years. It cannot target the exact location, tissue or region that needs to be treated.

Restraints:

                                                Adverse Effects of the Drugs

Advances in drug development have been very beneficial for treatment. However, these advanced complex drugs have some adverse effects on human health. For example, NSAIDs. Nonsteroidal anti-inflammatory drugs (NSAIDs) can relieve pain and reduce inflammation, but side effects can include stomach irritation, heart problems, and liver and kidney damage. Further, disease-modifying anti-rheumatic drugs (DMARDs) can slow the progression of psoriatic arthritis and prevent permanent damage to joints and other tissues. However, side effects can vary but can include liver damage, bone marrow suppression, and serious lung infections. This can act as a deterrent to the market.

Technological advancement

Key trends in the market include increasing involvement of government regulatory agencies to transform the healthcare and medical sector using new techniques, increasing drug adoption for psoriatic arthritis pain, drug launches, inorganic activities such as collaborations, and others. Recent technologies such as cytometry by time of flight (CyTOF), which detects heavy metals conjugated to cell-specific antibodies, and single-cell RNA sequencing (scRNAseq), based on the analysis of RNA expression in single cells—provide new insights into key effector cell subsets in the skin and Synovial fluid responsible for initiation and perpetuation of disease.

In September 2022, Pfizer Advances Vaccine Programs and Invests in Nimbus, Pfizer is leveraging funding and experience with vaccines for meningococcal, flu and RSV to further expand its presence in these areas. Pfizer's investigational pentavalent meningococcal vaccine was effective on all primary and secondary endpoints in a Phase III clinical trial in people aged 10 to 25 years.

Source: Prophecy Market Insights

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

The global psoriatic arthritis market is segmented based on the drug class, product type, route of administration and region.

Depending upon the drug class segment the global psoriatic arthritis market is divided into the DMARD, NSAIDs, biologics, and others. In terms of product type, the target market is segmented into OTC and prescriptions. Based on the route of administration, the target market is segmented into oral, topical, and injectable. The global active psoriatic arthritis market is segmented into prescription, OTC and others. The prescription segment dominated the other segments in terms of revenue share in the global market in 2020. Increasing prevalence of active psoriatic arthritis, increasing demand for advanced psoriatic arthritis treatments, and increasing sales of biologics and biosimilars as prescription drugs for psoriatic arthritis are some of them. Primary factors driving the revenue growth of this segment.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On region the Global Psoriatic Arthritis Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe, collectively dominates the global psoriatic arthritis market mainly due to the commercial sales of products in the U.S. In addition, the presence of key manufacturers, proactive government initiatives, favorable reimbursement policies, and a large patient pool support the psoriatic arthritis treatment market growth. Further the market is expected to grow the fastest in the regions of Asia Pacific due to the overall economic development, improvement in healthcare infrastructure, increase in disposable income, and rise in consumer awareness.

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD Billion & CAGR from 2020 to 2030
Market Segmentation	By Drug Class - DMARD, NSAIDs, Biologics, and Others By Product Type - OTC and Prescriptions By Route of Administration - Oral, Topical, and Injectable
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Global Psoriatic Arthritis Market report based on drug class, product type, route of administration and region:

Global Psoriatic Arthritis Market, By Drug Class:

• DMARD
• NSAIDs
• Biologics
• Others

Global Psoriatic Arthritis Market, By Product Type:

• OTC
• Prescriptions

Global Psoriatic Arthritis Market, By Route of Administration:

• Oral
• Topical
• Injectable

Global Psoriatic Arthritis Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the Global Psoriatic Arthritis Market includes AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., AstraZeneca plc; Bausch Health Companies Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer, Inc. and UCB S.A. Strategic. For instance, In September 2022 Acelyrin sets hopes high for arthritis drug with $300M fundraise. Bosch Health's Silics target the related IL-17 receptor A. Studies show that drugs that stop IL-17 from binding to its receptor can reduce inflammation, as well as swelling and pain. Many are approved to treat psoriatic arthritis and other inflammatory conditions.

In July 2022, Bausch takes hit in Xifaxan patent feud, potentially paving the way for Norwich's IBS-D generic. Bausch Health has been dealt a blow in court after other copycats of its irritable bowel syndrome diarrhea (IBS-D) drug Xifaxan were routed. The court order opens up the possibility of Norwich Pharmaceuticals' proposed generic entering the market.

• AbbVie Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Amgen Inc.
• Johnson & Johnson Services, Inc.
• AstraZeneca plc
• Bausch Health Companies Inc.
• Bristol-Myers Squibb Company
• Celgene Corporation
• Novartis International AG
• Eli Lilly and Company
• Pfizer, Inc.
• UCB S.A. Strategic.

 “*” marked represents similar segmentation in other categories in the respective section

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Psoriatic Arthritis Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Drug Class
     • Market Snippet, By Product Drug Class
     • Market Snippet, By Route of Administration
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Global Psoriatic Arthritis Market, By Drug Class, 2019 – 2029, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • DMARD
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • NSAIDs
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • Biologics
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
6. Global Psoriatic Arthritis Market, By Product Drug Class, 2019 – 2029, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • OTC
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • Prescriptions
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
7. Global Psoriatic Arthritis Market, By Route of Administration, 2019 – 2029, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Oral
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • Topical
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • Injectable
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
8. Global Psoriatic Arthritis Market, By Region, 2019 – 2029, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Route of Administration, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Route of Administration, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • Germany
       • UK
       • France
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Route of Administration, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • China
       • India
       • Japan
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Route of Administration, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Route of Administration, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
9. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
10. Company Profiles

• AbbVie Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Amgen Inc.
• Johnson & Johnson Services, Inc.
• AstraZeneca plc
• Bausch Health Companies Inc.
• Bristol-Myers Squibb Company
• Celgene Corporation
• Novartis International AG
• Eli Lilly and Company
• Pfizer, Inc.
• UCB S.A. Strategic

11. The Last Word
    • Future Impact
    • About Us
    • Contact

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Global Psoriatic Arthritis Market: Drug Class Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Drug Class

TABLE Global Psoriatic Arthritis Market, by Drug Class 2019-2029 (USD Million)

TABLE Global Psoriatic Arthritis Market: Product Type Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Product Type

TABLE Global Psoriatic Arthritis Market, by Product Type 2019-2029 (USD Million)

TABLE Global Psoriatic Arthritis Market: Route of Administration Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Route of Administration

TABLE Global Psoriatic Arthritis Market, by Route of Administration 2019-2029 (USD Million)

TABLE Global Psoriatic Arthritis Market: Regional snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Psoriatic Arthritis Market, by Region 2019-2029 (USD Million)

TABLE North America Psoriatic Arthritis Market, by Country, 2019-2029 (USD Million)

TABLE North America Psoriatic Arthritis Market, by Drug Class, 2019-2029 (USD Million)

TABLE North America Psoriatic Arthritis Market, by Product Type, 2019-2029 (USD Million)

TABLE North America Psoriatic Arthritis Market, by Route of Administration, 2019-2029 (USD Million)

TABLE Europe Psoriatic Arthritis Market, by Country, 2019-2029 (USD Million)

TABLE Europe Psoriatic Arthritis Market, by Drug Class, 2019-2029 (USD Million)

TABLE Europe Psoriatic Arthritis Market, by Product Type, 2019-2029 (USD Million)

TABLE Europe Psoriatic Arthritis Market, by Route of Administration, 2019-2029 (USD Million)

TABLE Asia Pacific Psoriatic Arthritis Market, by Country, 2019-2029 (USD Million)

TABLE Asia Pacific Psoriatic Arthritis Market, by Drug Class, 2019-2029 (USD Million)

TABLE Asia Pacific Psoriatic Arthritis Market, by Product Type, 2019-2029 (USD Million)

TABLE Latin America Psoriatic Arthritis Market, by Country, 2019-2029 (USD Million)

TABLE Latin America Psoriatic Arthritis Market, by Drug Class, 2019-2029 (USD Million)

TABLE Latin America Psoriatic Arthritis Market, by Product Type, 2019-2029 (USD Million)

TABLE Latin America Psoriatic Arthritis Market, by Route of Administration, 2019-2029 (USD Million)

TABLE Middle East and Africa Psoriatic Arthritis Market, by Country, 2019-2029 (USD Million)

TABLE Middle East and Africa Psoriatic Arthritis Market, by Drug Class, 2019-2029 (USD Million)

TABLE Middle East and Africa Psoriatic Arthritis Market, by Product Type, 2019-2029 (USD Million)

TABLE Middle East and Africa Psoriatic Arthritis Market, by Route of Administration, 2019-2029 (USD Million)

List of Figures

FIGURE Psoriatic Arthritis Market segmentation

FIGURE Market research methodology

FIGURE Value chain analysis

FIGURE Porter’s Five Forces Analysis

FIGURE Market Attractiveness Analysis

FIGURE COVID-19 Impact Analysis

FIGURE Pre & Post COVID-19 Impact Comparison Study

FIGURE Competitive Landscape; Key company market share analysis, 2019

FIGURE Drug Class segment market share analysis, 2019 & 2029

FIGURE Drug Class segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Product Type segment market share analysis, 2019 & 2029

FIGURE Product Type segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Route of Administration segment market share analysis, 2019 & 2029

FIGURE Route of Administration segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Regional segment market share analysis, 2019 & 2029

FIGURE Regional segment market size forecast and trend analysis, 2019-2029 (USD Million)

FIGURE North America Psoriatic Arthritis Market share and leading players, 2019

FIGURE Europe Psoriatic Arthritis Market share and leading players, 2019

FIGURE Asia Pacific Psoriatic Arthritis Market share and leading players, 2019

FIGURE Latin America Psoriatic Arthritis Market share and leading players, 2019

FIGURE Middle East and Africa Psoriatic Arthritis Market share and leading players, 2019

FIGURE North America market share analysis by country, 2019

FIGURE U.S. Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Canada Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Europe Psoriatic Arthritis Market share analysis by country, 2019

FIGURE Germany Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Spain Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Italy Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE UK Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE France Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Rest of the Europe Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Asia Pacific Psoriatic Arthritis Market share analysis by country, 2019

FIGURE India Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE China Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Japan Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE South Korea Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Rest of APAC Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Latin America Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Latin America Psoriatic Arthritis Market share analysis by country, 2019

FIGURE Brazil Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Mexico Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Argentina Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Rest of LATAM Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Middle East and Africa Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Middle East and Africa Psoriatic Arthritis Market share analysis by country, 2019

FIGURE Saudi Arabia Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE United Arab Emirates Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)

FIGURE Rest of Middle East and Africa Psoriatic Arthritis Market size, forecast and trend analysis, 2019-2029 (USD Million)